Atlas Trials

DP-R212 Pharmacokinetic Study

Clinical trial NCT02789475 · UNKNOWN

Trial details

NCT number
NCT02789475
Sponsor
Alvogen Korea
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
HypertensionHyperlipidemias
Start date
2016-05-01
Primary completion
2016-07-01
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.